Niki Hodges, DNP, APRN, FNP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14310 Highway 6, Santa Fe, TX 77517 Phone: 409-316-9085 Fax: 409-316-9014 |
News Archive
The report issued by the Department of Health and Human Services found that the number of children eligible but not enrolled in Medicaid and the Children's Health Insurance Program fell. Meanwhile, HHS also awarded $40 million in grants for more outreach.
As we age, the function and regenerative abilities of skeletal muscles deteriorate, which means it is difficult for the elderly to recover from injury or surgery. New work from Carnegie's Michelle Rozo, Liangji Li, and Chen-Ming Fan demonstrates that a protein called b1-integrin is crucial for muscle regeneration.
Merck, a leading science and technology company, today announced the relaunch of its brand identity. The fundamental revision of the visual appearance as well as the introduction of a new logo reflect the transformation into a global science and technology company. At the same time, the brand architecture at business level has been simplified. Outside the United States and Canada, the company will operate uniformly as Merck.
Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. have announced that the U.S. Federal Trade Commission ("FTC") has accepted the proposed consent order in connection with the pending acquisition of Barr by Teva and granted early termination of the Hart Scott Rodino waiting period.
The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.
› Verified 3 days ago